ask="8.50"
ask_size="500"
average_daily_volume="89436"
bid="6.30"
bid_size="300"
book_value="5.16"
change="+0.41"
change_from_200_day_moving_average="-3.43"
change_from_50_day_moving_average="0.52"
change_from_52_week_high="-10.02"
change_From_52_week_low="1.70"
change_in_percent="+5.39%"
close="8.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.47"
ebitda="-31.93M"
eps_estimate_current_year="-3.59"
eps_estimate_next_quarter="-0.72"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="12088000"
high="8.11"
high_52_weeks="18.03"
last_trade_date="2/1/2017"
last_trade_price="8.01"
last_trade_size="1133"
last_trade_time="4:00pm"
low="7.51"
low_52_weeks="6.31"
market_capitalization="145.73M"
moving_average_200_day="11.44"
moving_average_50_day="7.49"
name="Syndax Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.83"
open="7.55"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-30.01%"
percent_change_from_50_day_moving_average="+6.95%"
percent_change_from_52_week_high="-55.57%"
percent_change_from_52_week_low="+26.91%"
previous_close="7.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.47"
price_per_sales="113.33"
revenue="1.22M"
shares_outstanding="18193000"
short_ratio="0.80"
stock_exchange="NMS"
symbol="SNDX"
volume="58440"
weeks_range_52="6.31 - 18.03"
